Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Thruvision Group (THRU) by Steve Moore in ShareProphets
- Sell Fusion Antibodies (FAB) by Steve Moore in ShareProphets
- Avoid DP Poland (DPP) by Steve Moore in ShareProphets
- Avoid Corero Network Security (CNS) by Steve Moore in ShareProphets
- Watch Robert Walters (RWA) by Steve Moore in ShareProphets
- Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Avoid Oxford Instruments (OXIG) by Steve Moore in ShareProphets
- Watch Pagegroup (PAGE) by Steve Moore in ShareProphets
- Avoid Everyman Media Group (EMAN) by Steve Moore in ShareProphets
- Hold Burberry Group (BRBY) by William Kay in The Times - Tempus
- Avoid Cavendish Financial (CAV) by Tom Winnifrith in ShareProphets
- Avoid Thruvision Group (THRU) by Steve Moore in ShareProphets
- Avoid Hays (HAS) by Steve Moore in ShareProphets
- Avoid ActiveOps (AOM) by Steve Moore in ShareProphets
- Strong Buy KEFI Gold and Copper (KEFI) by Tom Winnifrith in ShareProphets
- Buy Marks & Spencer Group (MKS) by Robert Stephens (The Times) in The Times - Tempus
- Add Land Securities Group (LAND) by Harvey Jones in The Motley Fool
- Hold Mincon Group (CDI) (MCON) by Hot Stock Rockets in ShareProphets
- Avoid SIG (SHI) by Steve Moore in ShareProphets
- Watch Softcat (SCT) by Royston Wild in The Motley Fool
Valirx (VAL) Share Price
Health Care Sector
NOTE: This is based on 6 open tips for Valirx (VAL)
| Latest Bid : 0.12p | Latest Ask : 0.14p |
| High Today : 0.13p | Low Today : 0.12p |
| This Years High : 0.52p | This Years Low : 0.12p |
| Volume : 1,472,860 | MKT Cap : £0.17M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Valirx (VAL) Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.Valirx (VAL) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |
Valirx (VAL) Recent Short Position Updates
| Position | Date | |||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.12p | Latest Ask : 0.14p |
| High Today : 0.13p | Low Today : 0.12p |
| This Years High : 0.52p | This Years Low : 0.12p |
| Volume : 1,472,860 | MKT Cap : £0.17M |
Valirx Overview
ValiRx accelerates the development of treatments in cancer and women's health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Valirx Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2020-06-02 11:40:00 02/06/2020 | -11.45% |
| Sell | Nigel Somerville | Premium Only | 2020-04-02 11:45:00 02/04/2020 | -26,775.00% |
| Buy | Align Research Team | Premium Only | 2018-10-24 09:45:00 24/10/2018 | -73.13% |
| Sell | Nigel Somerville | Premium Only | 2016-04-02 11:00:00 02/04/2016 | 92.22% |
| Sell | Tom Winnifrith | Premium Only | 2015-09-17 15:14:45 17/09/2015 | 93.02% |